FilingSEC EDGAR8-K
Propanc Biopharma Plans to Appeal Nasdaq Delisting Notice
· SEC accepted
StageDelisting notice; appeal planned
Filing content
The company received the notice on October 23. An appeal by October 30 would stay delisting pending the panel's decision; without an appeal, delisting is scheduled for November 2.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…